There is now evidence to suggest that BRCA1 and BRCA2 are involved in the response of cells to DNA damage and cell cycle checkpoint control. This report examines the death pathways of human cells with various BRCA1 and BRCA2 genotypes after exposure to gamma-rays. A lack of functional BRCA1 and BRCA2 led to defective repair of DNA double-strand breaks in irradiated cells. This impairment resulted in a relaxation of cell cycle checkpoints, production of micronuclei, and a loss of proliferative capacity. Heterozygous BRCA1 and BRCA2 mutations also led to enhanced radiosensitivity, with an impaired proliferative capacity after irradiation. The existence of a phenotype related to radiosensitivity in BRCA1 +/7 and BRCA2 +/7 cells raises the question of the response of heterozygous women to radiation.
Introduction
The majority of hereditary breast and ovarian cancers are caused by germline mutations of the BRCA1 or BRCA2 genes (Miki et al., 1994; Wooster et al., 1995) . All the primary breast and ovarian tumors in women carrying a germline mutation in BRCA1 or BRCA2, have lost the wild-type allele inherited from the unaected parent. This suggests that these genes encode proteins with tumor suppressor activity. Although the precise function of these proteins has not been elucidated, there is now good evidence that the BRCA1 and BRCA2 gene products are involved in the response of the cell to DNA damage.
The BRCA1 protein has an N-terminal RING ®nger domain which may mediate protein ± protein and/or protein/DNA interactions and a BRCT motif at its Cterminus. This last motif is present in several proteins involved in DNA repair and cell cycle control (Bork et al., 1996; Callebaut and Mornon, 1997) . The BRCA1 and BRCA2 proteins are present in most human tissues and lie within the nucleus where they interact with other proteins such as RAD51, a human homolog of the bacterial RecA (Scully et al., 1997a; Wong et al., 1997) that is essential for DNA recombination (Bishop, 1994) . Scully et al. (1997b) have also reported that hyperphosphorylation of BRCA1 is triggered by DNA damaging agents (UV, gamma-rays, mitomycin C, etc.). Lastly, Abbott et al. (1998) reported that the human BRCA2
7/7
tumor cell line CAPAN-1 is hypersensitive to ionizing radiation and unable to repair DNA double-strand breaks (DSB) repair Hence, these data strongly suggest that BRCA1 and BRCA2 are involved in the cell response to genotoxic damage. BRCA1 and BRCA2 proteins also contribute to the control of the cell cycle (Chen et al., 1996) and transcription (Chapman and Verma, 1996) .
We have therefore examined the responses of human cells with various BRCA1 and BRCA2 genotypes to gamma-rays. We ®rst investigated their intrinsic radiosensitivity and three death pathways: (1) mitotic death, the most frequent pathway of radiation-induced cell killing which is accompanied by giant cells and micronuclei induction (D'Amico and McKenna, 1994) ; (2) apoptosis triggered by DSB and predominantly controlled by p53 (e.g. (Lowe et al., 1993; D'Amico and McKenna, 1994) ; (3) permanent arrest in G1, commonly observed in ®broblasts and controlled by p21/WAF1/Cip1/Kip1 (Li et al., 1995) . Since, DSB are mostly associated with lethal DNA lesions (Foray et al., 1997) , their repair rate was also measured in cells exposed to gamma-rays.
Results

p53 and p21 status and the response of cells to ionizing radiation
The status of p53 in all the lymphoblastoid cell lines used in this study has been established by functional assay in yeast (FASAY) (Flaman et al., 1995) . All the cells carried wild-type p53 except for the cells from LiFraumeni syndrome patients (p53
) (data not shown). The tumor cell lines HCC1937 and IGROV1 contained mutant alleles of p53 (Tomlinson et al., 1998) . Figure  1b shows the p53 and p21/WAF1/Cip1/Kip1 content of the cell types used in these experiments after exposure to gamma-rays. The content of p53 increased from a low basal level in the IGROV1 tumor cell line, whereas HCC1937 had a distinct basal level that increased slightly after irradiation. Irradiation caused an increase in p53 concentration in all the lymphoblastoid cell lines except heterozygous BRCA1 +/7 cells which had a high constitutive content of p53 that was not greatly changed by irradiation. The increase in p53 content was signi®cantly delayed in heterozygous p53 +/7 lymphoblastoid cells. The p53 concentration remained low in homozygous ATM 7/7 lymphoblastoid cells. The cell contents of p21/WAF1/Cip1/Kip1 roughly paralleled the amounts of p53 in all cell lines except HCC1937 cells, which had a measurable level of p53 but no detectable p21/WAF1/Cip1/Kip1 (Figure 1a ).
Sensitivity to ionizing radiation
The sensitivity of the cell lines to gamma-rays radiation was studied using a classical clonogenic assay which estimates the survival rate within a population of irradiated cells via the capacity of surviving cells to yield clonal populations. Homozygous ATM 7/7 lymphoblastoid cell lines were used as reference hypersensitive cell. The mean dose for a 37% survival (D37) was 0.55 Gy while the mean D37 was 2.05 Gy for the controls (Figure 2 ). HCC1937 tumor cells contain a defective BRCA1 protein (Tomlinson et al., 1998) and had enhanced radiosensitivity (D37=0.6 Gy), at the upper limit of the con®dence zone of the ATM 7/7 lymphoblastoid cell lines (Figure 2a,b) . The survival was 10% after a dose of radiation 3.5-fold lower than that required for control cell lines. IGROV1 tumor cells which are BRCA1 +/7 were less radiosensitive than HCC1937, but signi®cantly more sensitive than the control cell lines (Figure 2a lymphoblastoid cell lines were all hypersensitive to gamma-rays radiation, with mean D37 of 1.1 Gy and 0.95 Gy (Figure 2d,e) .
Thus the impairment of BRCA1 function led to a greater sensitivity to gamma-rays, comparable to that due to a lack of ATM. The sensitivity of cells that are heterozygous status for BRCA1 or BRCA2 but not for p53 raises question of gene dosage eect.
Radiation-induced cell death
Radiation-induced impairment of clonogenicity can be due to mitotic death, apoptosis or permanent arrest in G1.
(1) Mitotic death The formation of micronuclei and the accumulation of giant cells are major features of this response to radiation (Johnston et al., 1997) . Micronuclei are daughter-like cells which carry irreversibly damaged chromosome fragments. The yield of micronuclei after irradiation was measured by the cytokinesis block assay. The results of a time course experiment with lymphoblastoid cell lines are shown in Figure 3a . The ATM 7/7 cells had the highest yield of micronuclei, which increased linearly with repair time up to 72 h. Figure 3a shows (2) Apoptosis Apoptotic death was estimated by the ApopTag assay (Oncor, Gaithersburg, USA) for the same set of cells after gamma-rays irradiation (6 Gy). There was no evidence of signi®cant apoptotic death in HCC1937 or IGROV1 tumor cells (Figure 4a ), but 40 ± 50% of the irradiated normal lymphoblastoid cells showed apoptotic staining 72 h after irradiation. This response was not signi®cantly altered by the lack of ATM protein in ATM Figure 4b ). There was no correlation between apoptosis and D37 (P=0.8) suggesting that the type of radiation-induced death cannot account for the radiosensitivity of BRCA1 and BRCA2-mutated cell lines (data not shown).
Cell cycle progression in gamma-rays irradiated cells
The synthesis of radioresistant DNA re¯ects the capacity of a cell population to bypass the G1/S checkpoint. This checkpoint is relaxed in ATM 7/7 cells +/7 cells behaved similarly, whereas BRCA1 and BRCA2 heterozygotes had a phenotype intermediate between the relaxation of the G1/S checkpoint of ATM 7/7 cells and the stringency of the controls (Figure 5b ). Thus, there was no correlation between the D37 and the capacity of cells to control the G1/S checkpoint after irradiation (data not shown). All these cell lines underwent cyto¯uorometric cell cycle analysis 18 h after irradiation (6 Gy) ( Figure 6 ). There was no arrest of DNA synthesis in HCC1937 cells and the cells tended to accumulate in G2/M with a clearly heterogeneous DNA content. BRCA1 +/7 IGROV1 tumor cells responded mostly by arrest in G1 and no arrest of DNA synthesis (Figure 6a ). DNA synthesis was stopped in control lymphoblastoid cells which accumulated in G1 and G2/M phases of the cell cycle. By contrast, the ATM 7/7 lymphoblastoid cells lacked the checkpoint controls and did not stop DNA synthesis (Figure 6b ). p53 +/7 heterozygous lymphoblastoid cells showed a similar response (Figure 6d ). This is in agreement with the radioresistant DNA synthesis experiments described above. BRCA1 +/7 and BRCA2 +/7 heterozygous lymphoblastoid cells showed a pattern qualitatively similar to the controls, but dierent in the distinct heterogeneity of DNA contents of both G1 and G2/M arrested cells (Figure 6c ). This may be due to the partial radioresistant DNA synthesis mentioned above.
DSB repair rate
The DSB repair rate was measured by pulsed ®eld gel electrophoresis. Cells were irradiated at 48C (30 Gy) and incubated at 378C for 1 ± 6 h (for lymphoblastoid cells) or for 1 ± 24 h (for tumor cells). The HCC1937 cells showed very high residual damage, higher than ATM 7/7 lymphoblastoid cells, suggesting that the lack of a proper BRCA1 function leads to a de®cient DSB repair (42% of residual damage at 24 h). In parallel to Figure 7b shows the rates of DSB repair in lymphoblastoid cells, which indicated that approximately 50% of the lesions were repaired within the ®rst hour in all lymphoblastoid cells regardless of the genotype (Figure 7b ). Dierences appeared up to 6 h with marked defects in BRCA1
and BRCA2 +/7 and ATM 7/7 cells, for which 40 ± 50% of the damage remained unrepaired. Heterozygosity for p53 mutation did not seem to alter the eciency of DSB repair process (Figure 7b ). The correlation between unrepaired damage at 6 h and radiosensitivity was signi®cant (P=0.025) (data not shown).
Discussion
The hypothesis that BRCA1 acts as genome caretaker was ®rst put supported by the demonstration that BRCA1 interacts with the recombination-related Rad51 protein in mitotic and meiotic cells (Scully et al., 1997a) . Several other observations also support the concept that BRCA1 and BRCA2 are involved in monitoring and/or repairing DNA lesions. First, DNA damage aects the intracellular location and phosphorylation of BRCA1. The displacement of BRCA1 within the nucleus, after exposure of cells to DNA-damaging agents, indicates that BRCA1 moves to`sites of repair' (Scully et al., 1997a) . Second, BRCA1-Rad51 complexes are also found at sites where DNA breaks occur physiologically in the unpaired regions of developing synaptonemal complexes during meiosis (Scully et al., 1997a) . Last, Brca1 and Brca2 nullizygous mice are extremely radiosensitive (Connor et al., 1997; Sharan et al., 1997) .
HCC1937 cells were obtained from a tumor biopsy of a BRCA1 heterozygous woman. This cell line shows a loss of heterozygosity (LOH) aecting the BRCA1 wild-type allele which makes it unizygous for a truncated form of BRCA1. HCC1937 cells also have other genetic abnormalities that are likely to contribute to the malignant phenotype: they are unizygous for an allele of p53 mutated at codon 306 and carry an homozygous deletion of the PTEN gene (Tomlinson et al., 1998) . We have now shown that HCC1937 cells survive to gamma-rays, much like the well-known paradigms of radiosensitive human cell lines, such as ATM 7/7 (Foray et al., 1997; Shiloh, 1998) , Ligase IV-defective (Badie et al., 1995a) and the DNA-PKcs 7/7 (MO59J) cell lines (Lees-Miller et al., 1995) . Both ATM 7/7 and HCC1937 cells are 3 ± 4 fold more sensitive than controls. The BRCA2-mutated cell line, CAPAN-1, is also very sensitive to gamma-rays radiation (Abbott et al., 1998) . Therefore, the lack of functional BRCA1 or BRCA2 appears to allow the accumulation of genotoxic events following irradiation, which impairs their proliferative capacity. The multiple genetic events in addition to BRCA1 mutations in HCC1937 cells might also contribute to this. However, a lack of p53 function is generally associated with resistance to radiation rather than hypersensitivity (Lin et al., 1995; Levine, 1997) . There is no evidence that the PTEN gene product contributes to response to radiation although the PTEN product is an antagonist of anoikis (Davies et al., 1998) (Davies et al., 1998) .
Impaired BRCA1 function and the predominance of mitotic cell death Radiation-induced death can occur by mitotic death, apoptosis or irreversible arrest in G1. Mitotic death results in the production of micronuclei and giant cells (Johnston et al., 1997) . Micronuclei are produced by an aberrant progression through mitosis, which yields cells with a sub-genomic DNA content due to the loss of unrepaired chromosome fragments that are excluded from the normal course of mitosis. Recent observations have shown that radiation-induced micronuclei contain chromosome fragments holding RAD51, a protein partner of BRCA1 (Haaf et al., 1999) . Abnormal yields of spontaneous or radiation-induced micronuclei have been reported in cells from radiosensitive cancerprone patients and in breast adenocarcinoma cell lines (Otto et al., 1996; Barboule et al., 1997; Paglin et al., 1997) . Our data on ATM 7/7 cells are in good agreement with these published observations. HCC1937 cells yield radiation-induced micronuclei at a frequency similar to that of ATM 7/7 cells, thus supporting the notion that the absence of BRCA1 leads to an accumulation of unrepaired chromosome fragments. We ®nd an inverse correlation between the yield of micronuclei and the D37, indicating that mitotic death is the main pathway when BRCA1 function is impaired. This may be enhanced by a lack of alternative death pathways. Both BRCA1-induced JNK/SAPK-dependent (Harkin et al., 1999) and p53-induced apoptosis pathways must be defective. The absence of p21 protein prevents irreversible G1-arrest.
Cytometry of irradiated HCC1937 cells showed that the DNA content of the G2/M fraction was heterogeneous, with no production of tetraploid cells which would indicate a defect in the onset of cytokinesis. This may be due to the ®ring of a G2/M checkpoint operating on cells which have not accurately completed, indicating a relaxation in the licensing process (Chong and Blow, 1996) .
The production of abundant micronuclei in irradiated HCC1937 cells is a strong indication of persistent irreversibly damaged chromosomes. This damage was con®rmed by the rates of DSB repair, which showed that approximately 50% of the DNA lesions remain unrepaired 24 h after irradiation. This level of unrepaired damage also occurs in CAPAN-1 cells, which lack functional BRCA2 (Abbott et al., 1998) ; in ligase IV-defective 180BR ®broblasts (PA Jeggo, personal communication) (Badie et al., 1995) and in DNA-PKcs defective (MO59J) cell lines (LeesMiller et al., 1995) .
Heterozygous BRCA1 or BRCA2 mutations lead to radiation-sensitivity Mutant cells that are heterozygous for BRCA1 or BRCA2 all show a lower cell survival, higher yields of micronuclei, less apoptosis and fewer DSB repair defects in response to radiation, although these phenotypes are less severe than those of HCC1937 tumor cells. Heterozygous cells also have an heterogeneous DNA content suggesting that the p53 Whether this phenotype represents haploinsuciency or dominant-negative eect remains to be determined. It has been suggested that a predisposition to breast cancer in individuals who are members of breast cancer syndrome families may be linked to the capacity of circulating lymphocytes to produce a high degree of chromatid aberrations upon irradiation (Scott et al., 1994) . Lymphoblastoid cells from heterozygous p53
individuals also have phenotypic characteristics that distinguish them from wild-type cells, notably a resistance to radiation-induced apoptosis, in agreement with Delia et al. (1997) . Hence, the de®ciencies of the BRCA1 +/7 , BRCA2 +/7 or p53 +/7 cells may be the genetic basis for a predisposition to cancer in heterozygous carriers and raises question relative to the response of heterozygous women to radiation.
Materials and methods
Cell lines and cell culture conditions
EBV-immortalized lymphoblastoid cell lines were established from white blood cells from germline mutation carriers (IARC, Lyon, France) ( ) is a primary breast carcinoma cell line from a BRCA1 mutation carrier (Tomlinson et al., 1998) . It was cultured in DMEM medium supplemented with 20% FBS. IGROV1 is an ovarian tumor cell line heterozygote for a mutant BRCA1 allele (BRCA1 +/7 ) (Fajac et al., 1996) . The constitutional BRCA1 or BRCA2 genotype of the woman from whom the tumor was collected is not known. IGROV1 was cultured in RPMI medium supplemented with 20% FBS. The BRCA1 and BRCA2 mutations and the origin of the cell lines are presented in Table 1 .
Irradiation
Gamma-rays irradiation was performed at 48C with a gamma-rays 137 Cs-source (1.414 Gy.min 71 ) (Foray et al., 1997) .
P53 status
The p53 status was assayed with the functional assay in yeast (FASAY) developed by Flaman et al. (1995) .
Immunoblotting of p53 and of p21
Whole-cell extracts were prepared by lysing cells in EBC buer (50 mM Tris pH 8, 100 mM NaCl, 0.5% Nonidet P40) supplemented with 100 mg.ml 71 PMSF, 20 mg.ml 71 aprotinin, 10 g.ml 71 leupeptin, 50 mM NaF and 1 mM sodium orthovanadate. Cell extracts containing 60 mg of proteins were boiled in SDS ± PAGE loading buer for 3 min and separated by 9% SDS ± PAGE (7 h, 100V). The protein transfer onto nitrocellulose membrane (Schleicher and Schuell BA83) was performed with a liquid transfer method and the membrane blocked for 2 h in 5% milk solution. Anti-p53 (DO-7, Dako, Denmark) (1 : 100 dilution) or anti-p21 (Calbiochem, La Jolla, CA, USA) (1 : 50 dilution) monoclonal antibodies were applied overnight in 5% milk solution. After washing in PBS for 1 h, secondary peroxydase-labeled anti-mouse antibody (Jackson ImmunoResearch, West Grove, PA, USA) (1 : 5000 dilution) was applied in 5% milk solution for 1 h, the membrane was washed and the blotting revealed using an ECL kit (Amersham, Buckinghamshire, UK).
Clonogenicity assay
The intrinsic radiosensitivity was assessed for lymphoblastoid cells using the limit dilution technique (Evans et al., 1993) and for epithelial cell using the colonies method (Badie et al., 1995b) . Brie¯y, dilutions of live cells together with isolog feeder cells (30 Gy-irradiated) were seeded in 24 wells plates (lymphoblastoid cell lines) or in¯asks (tumor cell lines). The cell density including both feeder and live cells was adjusted to 10 4 cells per well for lymphoblastoid cells and 2.5 10 3 cells per cm 2 for tumor cells. The number of live cells ranges from 20 to 10 4 for lymphoblastoid cells and 100 to 10 5 for tumor cells. Exponentially growing cells were trypsinized, seeded at the appropriate density and irradiated 6 h after seeding. Colonies were scored after 2 weeks. With regard to lymphoblastoid cells, the lowest dilution giving colonies containing more than 50 cells were divided by the lowest dilution giving colonies without irradiation. With regard to tumor cell lines, colonies were ®xed in absolute ethanol and stained with crystal violet. The number of colonies containing more than 50 cells was scored and divided by the plating eciency of non-irradiated cells. Data were plotted on a semi-log scale and ®tted to the linear-quadratic model. For both cell types, the radiosensitivity was quanti®ed by calculating the inactivation dose for 37% survival (D37).
Micronuclei assay
The cytokinesis block technique was used to assess the production of micronuclei which is known to correlate with the extent of radiation-induced chromosomal damage (Liu and Bryant, 1993) . Brie¯y, 3 mg.ml 71 of cytochalasin B (Sigma, St. Louis, MI, USA) was added to cell cultures after exposure to 6 Gy. Cells were incubated up to 72 h, ®xed in methanol-acetic acid (3 : 1) and stained in 10% Giemsa. Micronuclei were scored by optical microscopy in binucleated cells on a total of at least of 200 cells. The yield of spontaneous micronuclei was subtracted from the raw data and expressed per 100 cells. It ranges from 15% for all the lymphoblastoid cells up to 40% for HCC cells. 
